|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Calliditas Therapeutics (NASDAQ: CALT) through any online brokerage.
The latest price target for Calliditas Therapeutics (NASDAQ: CALT) was reported by Stifel on June 30, 2020. The analyst firm set a price target for 28.00 expecting CALT to fall to within 12 months (a possible -1.93% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Calliditas Therapeutics (NASDAQ: CALT) is $28.55 last updated Today at 4:14:09 PM.
There are no upcoming dividends for Calliditas Therapeutics.
There is no upcoming split for Calliditas Therapeutics.
Calliditas Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.